Member Info for dan1nat1

pi's getting rinsed, and the big trades are still all buys!

Buys coming back

And the larger trades are still all buys...

Peel playing those games again, they will switch to the bid again soon then the afternoon fun can begin.

I can sell at 82p, looks like more orders being filled to me. This recovery has only just started.

Peel really pushed the bid to fill the last purchase by Tom-Erik Lind, I wonder if we have another large buyer in the background?

It's great when Peel want stock ;)

Due Q3 teabiscuit

There are only 31m shares in issue, I would be surprised if they were not always low on stock. That is the main reason we can expect to fly to £8+ so quick on the sniff of good news.

Do they not mean that is the best they have been quoted?

80p will be significant, if we can close above it I expect we will be back to £1+ in no time, as the positive correction in confirmed.

You have to laugh...the small holders panic and sell, while the largest trades of the morning have been taking the chance to buy in cheap.

Don't speak to soon FARN loves an afternoon reversal...

I will not be surprised to see this finish +15% - 20% today, even now at -14%, this one moves fast and hard!

Good post Tomie, and I’m still not ruling out admistration error based on the low mortality of the placebo group.

“We have observed that a subgroup of patients with higher levels of biomarkers in the INTEREST trial did demonstrate reduced mortality and increased ventilator free days, as expected based on the positive Phase II study," said Faron chief executive officer Dr Markku Jalkanen.

"While this is encouraging this still does not explain many of the other results observed from the trial including why Traumakine activity was variable in the INTEREST trial compared to previous studies nor the low mortality of the placebo group.”

To add to Berties post, despite the inconclusive European phase 3 test Traumakine is still described as there lead drug. All is still being played for especially with the Japanese results due any time now. When SUMM had a phase 3 failure last month, all mention of the drug was removed from the company website within days, and they moved onto the next thing. FARN clearly still see Traumakine has legs! FARN RNS 8th August - “The Company's lead candidate Traumakine, to prevent vascular leakage and organ failures, has completed a Phase III clinical trial in Acute Respiratory Distress Syndrome (ARDS). An additional European Phase II Traumakine trial is underway for the Rupture of Abdominal Aorta Aneurysm ("RAAA"). Faron's second candidate Clevegen is a ground breaking pre-clinical anti-Clever-1 antibody. Clevegen has the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development. This novel macrophage-directed immuno-oncology switch called Tumour Immunity Enabling Technology ("TIET") may be used alone or in combination with other immune checkpoint molecules for the treatment of cancer patients. Faron is based in Turku, Finland. Further information is available at www.faron.com”

Same again tomorrow?

No sure we can complain at a 23% one day rise ;)

I thought we may have seen more action in the run up to tomorrows presentation.

When £1.50 breaks, today's action will look small fry!